Beijing Aosaikang Pharmaceutical Co., Ltd. (SHE:002755)
China flag China · Delayed Price · Currency is CNY
15.00
+0.48 (3.31%)
Mar 10, 2026, 3:04 PM CST

SHE:002755 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2015
Cash & Equivalents
1,3851,4111,047772.711,1661,369
Upgrade
Trading Asset Securities
1,091683.28713.83839.08522.39100
Upgrade
Cash & Short-Term Investments
2,4762,0951,7611,6121,6881,469
Upgrade
Cash Growth
18.86%18.96%9.25%-4.51%14.90%14.14%
Upgrade
Accounts Receivable
293.43231.83181.24323.03581.86968.27
Upgrade
Other Receivables
8.4113.0249.8825.2116.2924.79
Upgrade
Receivables
301.84244.85231.12348.23598.15993.06
Upgrade
Inventory
126.88196.99167.49141.53141.84168.74
Upgrade
Other Current Assets
36.9631.592736.5659.1416.01
Upgrade
Total Current Assets
2,9412,5682,1862,1382,4872,647
Upgrade
Property, Plant & Equipment
423.21474.03478.4547.14658.33706.66
Upgrade
Long-Term Investments
48.33118.72118.21107.57105.1877.36
Upgrade
Other Intangible Assets
547.22146.3498.3495.7797.6984.91
Upgrade
Long-Term Deferred Tax Assets
24.6624.6225.7325.8528.6926.9
Upgrade
Long-Term Deferred Charges
409.57676.78563.46453.7342.02257.47
Upgrade
Other Long-Term Assets
41.7238.9753.2646.225.757.89
Upgrade
Total Assets
4,4364,0483,5243,4143,7253,808
Upgrade
Accounts Payable
40.9559.9838.2939.0865.7295.29
Upgrade
Accrued Expenses
9.7440.8443.6119.56133.48299.13
Upgrade
Short-Term Debt
4762114.0245.03-20.01
Upgrade
Current Portion of Leases
2.334.063.033.452.61-
Upgrade
Current Income Taxes Payable
20.292.053.592.137.5413.14
Upgrade
Current Unearned Revenue
230.95108.5115.8811.6815.2631.18
Upgrade
Other Current Liabilities
732.08543.53213.14102.81177.11231.23
Upgrade
Total Current Liabilities
1,083820.96431.55323.74401.71689.99
Upgrade
Long-Term Leases
3.856.626.758.9211.52-
Upgrade
Long-Term Unearned Revenue
60.3260.6664.7255.8168.9369.41
Upgrade
Long-Term Deferred Tax Liabilities
17.1517.1510.1812.5615.0815.49
Upgrade
Total Liabilities
1,165905.39513.2401.03497.24774.89
Upgrade
Common Stock
928.16928.16928.16928.16928.16928.16
Upgrade
Additional Paid-In Capital
164.17136.94136.9450.730.941.49
Upgrade
Retained Earnings
2,1011,9891,8281,9772,2952,101
Upgrade
Comprehensive Income & Other
11.978.956.587.25-5.9-3.7
Upgrade
Total Common Equity
3,2053,0632,9002,9633,2193,027
Upgrade
Minority Interest
66.7379.59110.750.378.826.06
Upgrade
Shareholders' Equity
3,2723,1423,0113,0133,2283,033
Upgrade
Total Liabilities & Equity
4,4364,0483,5243,4143,7253,808
Upgrade
Total Debt
53.1872.67123.857.4114.1320.01
Upgrade
Net Cash (Debt)
2,4232,0221,6371,5541,6741,449
Upgrade
Net Cash Growth
22.34%23.52%5.32%-7.14%15.51%12.58%
Upgrade
Net Cash Per Share
2.522.141.761.651.811.57
Upgrade
Filing Date Shares Outstanding
928.16928.16928.16928.16928.16928.16
Upgrade
Total Common Shares Outstanding
928.16928.16928.16928.16928.16928.16
Upgrade
Working Capital
1,8581,7471,7551,8142,0851,957
Upgrade
Book Value Per Share
3.453.303.123.193.473.26
Upgrade
Tangible Book Value
2,6582,9162,8022,8673,1212,942
Upgrade
Tangible Book Value Per Share
2.863.143.023.093.363.17
Upgrade
Buildings
-385.96375.5371.29437.94436.85
Upgrade
Machinery
-804.36744.21767.2776.51764.36
Upgrade
Construction In Progress
-23.5136.0729.819.7115.72
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.